Abbott’s New XIENCE Sierra Drug-Eluting Coronary Stent Released in Europe

Abbott is introducing in Europe its XIENCE Sierra stent following receipt of the CE Mark of approval. The device is based on the popular XIENCE everolimus-eluting stent platform.

The new installment of the XIENCE features a narrower profile, greater flexibility, and available in longer lengths and smaller diameters, compared to previous device gen (Read more...)

Full Story →